Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Beginning Cash Balance (2023 - 2025)

BioScience Health Innovations (BHIC) has disclosed Beginning Cash Balance for 3 consecutive years, with $990000.0 as the latest value for Q4 2025.

  • Quarterly Beginning Cash Balance rose 203.22% to $990000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Dec 2025, up 145.39% year-over-year, with the annual reading at $3.2 million for FY2025, 195.04% up from the prior year.
  • Beginning Cash Balance for Q4 2025 was $990000.0 at BioScience Health Innovations, up from $800000.0 in the prior quarter.
  • The five-year high for Beginning Cash Balance was $990000.0 in Q4 2025, with the low at $17952.0 in Q1 2023.
  • Average Beginning Cash Balance over 3 years is $425649.4, with a median of $306300.0 recorded in 2024.
  • Peak annual rise in Beginning Cash Balance hit 1493.69% in 2024, while the deepest fall reached 31.6% in 2024.
  • Over 3 years, Beginning Cash Balance stood at $248093.0 in 2023, then surged by 31.6% to $326500.0 in 2024, then surged by 203.22% to $990000.0 in 2025.
  • According to Business Quant data, Beginning Cash Balance over the past three periods came in at $990000.0, $800000.0, and $522000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.